• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/13

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

13 Cards in this Set

  • Front
  • Back
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
• ELECTRICAL CONDUCTION -4
– Sino-atrial node - pacemaker
– Atrio-ventricular node - regulator
– Bundle of His
– Purkinje fibers
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
CONTRACTION PHYSIOLOGY
• ELECTRICAL CURRENT
• CALCIUM RELEASED TO SARCOPLASM
• INERACTS WITH TROPONIN
• ACTIN-MYOSIN COUPLING
• CONTRACTION
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
ACTION POTENTIAL
# of phases? what occurs at each phase?
• PHASE 0 - Fast sodium Channel
• PHASE 1 - Mild repolarization
• PHASE 2 - Slow calcium channel
• PHASE 3 - Repolarization (potassium enters cell)
• PHASE 4 - Resting (sodium/potassium pump)
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
FRANK-STARLING CURVE
-3
• CARDIAC OUTPUT (heart rate times stroke volume) graphed versus left ventricular end diastolic pressure
• Cardiac Output increases with pressure up to a point of congestive heart failure.
• Cardiac glycosides shift the curve of the graph
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
LOW OUTPUT FAILURE
• Congestive Heart Failure
• Treatment-4
– Diet - weight loss/low sodium/low fat
– Diuretics
– Cardiac Glycosides
– ACE inhibitors
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
CARDIAC GLYCOSIDE PHARMACOLOGY
• INCREASED CONTRACTILITY OF HEART
– Increased inotropic effect
– Cannot pump calcium out of cardiac cell
– Leads to greater contractility and duration
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
• DECREASED A-V NODE CONDUCTION
– Decreased chronotropic effect
– Used in atrial fibrillation
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
THERAPEUTIC MONITORING
• Apical Pulse
– Hold dose for <60
• Serum drug level
– Narrow therapeutic index
• Serum potassium- caution in hypokalemia
• Serum Calcium- caution in hypercalcemia
• EKG
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
PHARMACOKINETICS
4
• Five half lives leads to steady state
• Loading Doses required
• Toxicities - reversed by digoxin immune fab (Digibind®)
• HALF LIFE
– DIGOXIN - 24 HOURS
– DIGITOXIN - 5 days
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
BIOAVAILABILITY
3
• INTRAVENOUS - 100%
• INTRAMUSCULAR - 80%
• TABLET - 70%
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
TOXICITIES
5
• A-V BLOCK
• SINUS BRADYCARDIA
• ARRHYTHMIAS
• YELLOW-GREEN HALO VISION
• CNS: Headache, weakness, anorexia
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
TOXICITY THERAPY
4
• Discontinue Cardiac Glycoside
• Digoxin immune fab (Digibind®)
• Correct hypokalemia
• Antiarrhythmic Agents
CARDIAC GLYCOSIDES
CARDIAC PHYSIOLOGY
THERAPEUTIC USES
• CONGESTIVE HEART FAILURE

• ADJUNCT THERAPY FOR ATRIAL FIBRILLATION